Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
With
Novartis
Number of participants with Adverse events will be covered in Adverse Events section.
The statistical analysis tests for the efficacy variables will be performed hierarchically. The comparisons ciprofloxacin DPI vs. pooled placebo (according to statistical analysis plan defined for FDA registration) will be performed in parallel for the regimen 28 days on/off and 14 days on/off.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with a proven and documented diagnosis of non Cystic Fibrosis (CF) idiopathic or post infectious bronchiectasis
Stable pulmonary status and stable regimen of standard treatment at least for the past 4 weeks
You may not be if
Forced expiratory volume in 1 second (FEV1) \<30% or \>90% predicted
Active allergic bronchopulmonary aspergillosis
Active and actively treated non tuberculosis mycobacterial (NTM) infection or tuberculosis
Primary diagnosis of Chronic obstructive pulmonary disease (COPD)
Clareo Health | Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
